These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. In vitro susceptibilities of 176 clinical isolates of Streptococcus pneumoniae to 11 beta-lactams, erythromycin, and tetracycline. Vanhoof R, Carpentier M, Glupczynski Y, Gordts B, Magerman K, Nyssen HJ, Simon A, Surmont I, Van de Vyvere M, Van Landuyt H, Van Nimmen L, Van Noyen R. Acta Clin Belg; 1996; 51(6):377-85. PubMed ID: 8997755 [Abstract] [Full Text] [Related]
10. Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci. Pankuch GA, Jacobs MR, Appelbaum PC. J Antimicrob Chemother; 1995 Jun; 35(6):883-8. PubMed ID: 7559200 [Abstract] [Full Text] [Related]
11. Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents. Peric M, Browne FA, Jacobs MR, Appelbaum PC. Clin Ther; 2003 Jan; 25(1):169-77. PubMed ID: 12637118 [Abstract] [Full Text] [Related]
13. In-vitro activities of 16 non-beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae. Verhaegen J, Verbist L. J Antimicrob Chemother; 1999 Apr; 43(4):563-7. PubMed ID: 10350388 [Abstract] [Full Text] [Related]
14. MIC and time-kill studies of antipneumococcal activity of GV 118819X (sanfetrinem) compared with those of other agents. Spangler SK, Jacobs MR, Appelbaum PC. Antimicrob Agents Chemother; 1997 Jan; 41(1):148-55. PubMed ID: 8980771 [Abstract] [Full Text] [Related]
15. Comparative activity of the new fluoroquinolone Bay y3118 against 177 penicillin susceptible and resistant pneumococci. Spangler SK, Jacobs MR, Appelbaum PC. Eur J Clin Microbiol Infect Dis; 1993 Dec; 12(12):965-7. PubMed ID: 8187796 [Abstract] [Full Text] [Related]
16. Choice of an oral beta-lactam antibiotic for infections due to penicillin-resistant Streptococcus pneumoniae. Goldstein FW. Scand J Infect Dis; 1997 Dec; 29(3):255-7. PubMed ID: 9255885 [Abstract] [Full Text] [Related]
17. Time-kill studies on susceptibility of nine penicillin-susceptible and -resistant pneumococci to cefditoren compared with nine other beta-lactams. Spangler SK, Jacobs MR, Appelbaum PC. J Antimicrob Chemother; 1997 Feb; 39(2):141-8. PubMed ID: 9069533 [Abstract] [Full Text] [Related]
18. [In vitro comparative effect of cefixime and 7 other beta-lactamines against Streptococcus pneumoniae]. Boussougant Y, Weber P. Presse Med; 1989 Oct 11; 18(32):1553-5. PubMed ID: 2530530 [Abstract] [Full Text] [Related]
19. In vitro susceptibility of pneumococci to trovafloxacin, penicillin G, and other antimicrobial agents in the Czech Republic and Slovakia. Urbásková P, Trupl J, Hupková H, Appelbaum PC, Jacobs MR. Eur J Clin Microbiol Infect Dis; 1996 Aug 11; 15(8):686-8. PubMed ID: 8894582 [Abstract] [Full Text] [Related]
20. Influence of penicillin/amoxicillin non-susceptibility on the activity of third-generation cephalosporins against Streptococcus pneumoniae. Fenoll A, Giménez MJ, Robledo O, Aguilar L, Tarragó D, Granizo JJ, Martín-Herrero JE. Eur J Clin Microbiol Infect Dis; 2008 Jan 11; 27(1):75-80. PubMed ID: 17943330 [Abstract] [Full Text] [Related] Page: [Next] [New Search]